Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators. - Wikidata - awgldk - TriplyDB

Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators.

Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators.

http://www.wikidata.org/entity/Q33642619

about

Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2 A Survey of Strategies to Modulate the Bone Morphogenetic Protein Signaling Pathway: Current and Future Perspectives Satellite cells in human skeletal muscle plasticity The quasi-parallel lives of satellite cells and atrophying muscle Whole-exome sequencing reveals TopBP1 as a novel gene in idiopathic pulmonary arterial hypertension Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy Minireview: progress and challenges in proteomics data management, sharing, and integration Redundancy of myostatin and growth/differentiation factor 11 function Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy.Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic mice Combination of myostatin pathway interference and dystrophin rescue enhances tetanic and specific force in dystrophic mdx mice Intertissue control of the nucleolus via a myokine-dependent longevity pathway.Regulation of muscle mass by follistatin and activins METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11.Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation Is Growth Differentiation Factor 11 a Realistic Therapeutic for Aging-Dependent Muscle Defects?Extracellular Regulation of Myostatin: A Molecular Rheostat for Muscle Mass.An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin Adult-specific systemic over-expression reveals novel in vivo effects of the soluble forms of ActRIIA, ActRIIB and BMPRII.Highly specific detection of myostatin prodomain by an immunoradiometric sandwich assay in serum of healthy individuals and patients.The role of myostatin in muscle wasting: an overview Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth Endocrine actions of myostatin: systemic regulation of the IGF and IGF binding protein axis.BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.Role of IGF-I in follistatin-induced skeletal muscle hypertrophy.Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy Administration of an activin receptor IIB ligand trap protects male juvenile rhesus macaques from simian immunodeficiency virus-associated bone loss.The promise of recombinant BMP ligands and other approaches targeting BMPR-II in the treatment of pulmonary arterial hypertension Circulating Growth Differentiation Factor 11/8 Levels Decline With Age.Large-scale isolation of human skeletal muscle satellite cells from post-mortem tissue and development of quantitative assays to evaluate modulators of myogenesis.Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy.Through thick and thin: a circulating growth factor inhibits age-related cardiac hypertrophy.Activin signaling as an emerging target for therapeutic interventions An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy.A myostatin inhibitor (propeptide-Fc) increases muscle mass and muscle fiber size in aged mice but does not increase bone density or bone strength.Activin receptor antagonists for cancer-related anemia and bone disease.The ESA scenario gets complex: from biosimilar epoetins to activin traps.The Prodomain-bound Form of Bone Morphogenetic Protein 10 Is Biologically Active on Endothelial Cells.Expression Profiling of Activin type IIB Receptor During Ontogeny in Broiler and Indigenous Chicken.Investigational therapies for renal disease-induced anemia.

P2860

Q24323503-0B89D819-E7D0-42DC-BE0F-E3519B1C7CA8 Q26739015-C26F43D1-02B9-4C95-B7CF-83B354107D22 Q26777962-B08D2D23-336B-440C-A3B0-F4C5F9E67579 Q26800207-CE6C0F4D-C5BE-4F51-B251-AB708516D387 Q28237461-45A455C7-B117-4229-9E13-15F54E383B10 Q28290417-C42B97C7-3546-468D-9B4A-A1687D59E635 Q28727478-EFAB754D-DDDB-4B8F-985B-7BDB1620A2BB Q33419706-AE634FC5-63BE-451D-92FC-244B4D845E6A Q33877924-1C51DB26-1265-4EB0-8ED0-BFE10379E901 Q33881904-53622A88-FEA6-4F5F-8076-FF59A0CE1255 Q33931629-9F98E210-EAF5-42E5-B65B-0A37C1928BD9 Q34018412-8DB706B4-8BA5-4D41-AC9D-BD8E84A57CD7 Q34197249-CD6A36CB-62F0-48FD-8764-682161851B5F Q34447001-DF0789A5-946F-4AD7-A7F3-BEA423D7C460 Q34520504-00734D0D-AFEC-48B9-825C-C8B20D21FD2E Q34520509-A0E79D22-3258-4D96-929D-8FE79E9D32A6 Q34694932-851DA43B-2862-4411-946C-AE5FE2B3B905 Q34803626-CD0B5D96-463E-43AC-9C2E-682DF03F296A Q35035999-FFD2A706-1CF6-4B9B-8202-7A1D219A9364 Q35049028-56561FD5-1C17-49D1-B0B0-647028AF8A86 Q35223987-CB82BD40-02DB-43E4-B78A-52AF536C49B9 Q35314203-C88A87D9-E2AB-4A28-A66F-30C79A10E34B Q35558460-12330181-4438-48DF-8E46-67A04DFED677 Q36057921-F5E35161-FF98-452D-A694-5B8303F900EC Q36066585-33CDA9CA-BBBE-4BD4-BDD7-E416C0CF9DAE Q36199822-79A7A910-BC94-4D0C-9DB3-6A61D87AEA36 Q36263420-7D893A8B-7729-442E-AF15-1A55367BF5B9 Q36457064-1770D2B1-6095-4475-A83E-E9F264F60600 Q36566423-0236ADAD-E930-4CB9-9AE7-6572F4081409 Q36935002-717009F7-F29C-4427-BF48-DCCAF121F9F7 Q37140393-B2D8D652-0BB9-416A-8404-5B78D61685F9 Q37238641-FD05EB3B-94AA-491C-BBBC-CC06B5C5E18D Q37268461-052AD64C-EE3A-4AC2-9F75-DF884BFFF1E3 Q37546849-57C21507-E4DC-44D3-96D2-9600D5DA473E Q37595428-C2ECD19F-AAD7-4C60-BAD1-0FA6F6D43222 Q38057813-B9DF365D-2BB7-461E-86B9-5CF0FE1EE7C8 Q38205752-E61B8705-B882-47FC-90B3-5E4B2C92AD76 Q38265566-B9297CCE-0343-4BF5-9482-E60E04BBBB4E Q38444077-6E1A6EB8-D5D6-443E-8867-EE2073F3C6D9 Q38819455-7ABDBA30-425A-48E5-85C8-423D25F31AD2

P2860

Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators.

http://www.wikidata.org/entity/Q33642619

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Proteomic identification and f ...... novel muscle mass regulators.

@ast

Proteomic identification and f ...... novel muscle mass regulators.

@en

type

label

Proteomic identification and f ...... novel muscle mass regulators.

@ast

Proteomic identification and f ...... novel muscle mass regulators.

@en

prefLabel

Proteomic identification and f ...... novel muscle mass regulators.

@ast

Proteomic identification and f ...... novel muscle mass regulators.

@en

P1433

Q33642619-7D98A96D-CB21-42DE-9177-1D479EC58381

P1476

Q33642619-92C23E48-CCE9-4005-A904-33FFBF28A836

P2093

Q33642619-02B1758D-6EA1-4D07-BA54-04A633A21F4A

Q33642619-07CF7668-1A41-4F70-ABF5-FA75EFFC67DF

Q33642619-188CBB0D-1166-4F34-999C-0EF139D3848C

Q33642619-48A723A7-1B3F-4750-A586-0FBF8448EDBA

Q33642619-6888F146-B1EB-4241-8933-3152494C69FA

Q33642619-B22AB7B2-0429-4191-A48B-3FB28966A2EF

Q33642619-D658AFAF-AF61-4FBA-BC16-4A63C1CC5E83

Q33642619-E4D9C24E-25CA-4EBD-B4CF-84AA399E6CD7

P2860

Q33642619-046D6FFC-B2ED-4831-A5BE-6C71E5F3E077

Q33642619-0B433DC4-924F-40E1-B800-FDFC75AC8BAF

Q33642619-0EE3B64C-828C-49D0-B006-B8FE66E72B53

Q33642619-0F839348-7543-4C6C-A1EA-D1DD09300465

Q33642619-1202E560-C50C-440C-97C1-DCF4D71731FD

Q33642619-1251AFD1-35BD-49A6-AA6D-FFECD71AA890

Q33642619-130135AE-BAE0-442A-928E-120DF9A7D9EB

Q33642619-1661AF30-F692-4DDB-8C55-15FADD76D4BD

Q33642619-23E8D75B-8F1D-4C1A-8531-E2B899340587

Q33642619-28F66286-DEDD-4FF9-9EA2-19C030BA6BA7

P304

Q33642619-3809AE2B-220C-4654-90CC-29FD21BF2E9D

P31

Q33642619-4672D3DD-990F-47D0-A773-7D8435A8C449

P356

Q33642619-C50731E0-B82A-4D0A-A3A9-22883F207961

P433

Q33642619-F46CDC77-AC5B-4238-838B-76B342373889

P478

Q33642619-7E62AB52-FF7C-4B8B-BD76-D0A1CD8325F7

P577

Q33642619-422D92D9-8A11-4089-9FA4-B6CDEF64C81A

P5875

Q33642619-F7B4AC49-5908-405E-8201-893A70F8AAF5

P698

Q33642619-92624A98-5049-4636-B150-3D3627BC4F62

P921

Q33642619-6640021D-7B73-4A75-8A45-756F0F202686

P932

Q33642619-F3F152FD-E9E6-411E-87AC-7E62C73800F9

P356

P1433

Molecular Endocrinology

P1476

Proteomic identification and f ...... novel muscle mass regulators.

@en

P2093

Jennifer J Hill

http://www.w3.org/2001/XMLSchema#string

Jimin Zhang

http://www.w3.org/2001/XMLSchema#string

Parid Sava

http://www.w3.org/2001/XMLSchema#string

Paul J Yaworsky

http://www.w3.org/2001/XMLSchema#string

Tatyana A Souza

http://www.w3.org/2001/XMLSchema#string

Xuan Chen

http://www.w3.org/2001/XMLSchema#string

Yongchang Qiu

http://www.w3.org/2001/XMLSchema#string

Yongjing Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways

A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs

Heart specific expression of mouse BMP-10 a novel member of the TGF-beta superfamily

Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis

Novel regulators of bone formation: molecular clones and activities

Myostatin mutation associated with gross muscle hypertrophy in a child

Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells

The myoD gene family: nodal point during specification of the muscle cell lineage

GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells

Regulation of muscle growth by multiple ligands signaling through activin type II receptors.

P304

2689-2702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/ME.2008-0290

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23388730

http://www.w3.org/2001/XMLSchema#string

P698

18927237

http://www.w3.org/2001/XMLSchema#string

P921

P932

5419403

http://www.w3.org/2001/XMLSchema#string